HeyJaredSai Prabhakar
- Indexed articles, last 90 days
- 7
- Latest publication
- Aug 29, 2026
- Outlet visibility, for The Hindu BusinessLine
- Top 50K sites
- Earliest in this view
- Jul 4, 2026
Latest articles
Five Investor Choices That Matter Now (opens the original)
Read excerpt
Nifty 50 has been unusually range-bound and declined 2 per cent in the last two years compared with a 42 per cent return in the two years prior to this. It is quite clear that market dynamics are changing from the post-Covid years. During that phase, improving fundamentals were turbocharged by easy money and positive sentiment. However, in the last two years, support from liquidity and sentiment has been waning, reflected in flattish headline index performance with deeper pain in stocks. Close t
Symbiotec Pharmalab IPO analysis: Key factors investors need to know before subscribing (opens the original)
Read excerpt
Symbiotec Pharmalab is a bio-pharmaceutical company with a leading position in fermentation-based hormone and steroid APIs. Its IPO is scheduled for August 24-27. At the upper end of the price band, the issue is valued at 57.8 times FY26 EPS. While this is a premium valuation, it is supported by several long-term growth drivers: steady expansion in the core API business, CDMO opportunities, complex injectables, and insulin and GLP-1 manufacturing. Strong R&D capabilities, which act as a moat, an
The rising cost of falling ill (opens the original)
Read excerpt
A parliamentary committee is considering caps on hospital room rents, linked to local three-star hotel rates, as well as limits on surgery costs. The proposal aims to contain medical inflation, which has accelerated since the post-Covid period. To examine the issue from an insurance and claims perspective, we look at data released by Policybazaar.com. The insurance aggregator and composite broker analysed 8.7 lakh health insurance claims filed between 2021 and 2026. The study highlights how age,
Freedom to Invest With Balance Sheet Strongest in Many Years (opens the original)
Read excerpt
Each quarter, India Inc’s profit numbers hog the limelight, while another set of numbers — crucial for sustaining profits for the long term — get lesser attention than they deserve: Balance-sheet strength. Stronger balance sheets allow for more aggressive investments which can drive growth in future. In this analysis, we do a status check on balance-sheet strength of India Inc. Over the past five years, India Inc has had to navigate an unusually turbulent economic landscape. The pandemic, geopol
India Inc throws up a pleasant surprise in Q1 as compared to gloom at the start of the quarter (opens the original)
Read excerpt
Under the full glare of the Middle East conflict, India Inc’s performance paints an optimistic picture despite relatively flat earnings growth. Of the 4,220 companies that had reported results till Friday, revenue and PAT grew 21 per cent and 14 per cent YoY, respectively. This indicates strong revenue growth that has not fully translated into the bottom line owing to higher material costs. The divergence is more pronounced when the 593 BFSI companies are excluded, with revenue and adjusted PAT
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For The Hindu BusinessLine, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.